LN-969132
3-nitro-N-(4-phenoxyphenyl)-benzamide , 98% HPLC , 316146-57-3
Update time: 2023-04-23
PRODUCT Properties
Boiling point: | 430.9±30.0 °C(Predicted) |
Density | 1.333±0.06 g/cm3(Predicted) |
storage temp. | room temp |
solubility | DMSO: >20mg/mL |
pka | 11.76±0.70(Predicted) |
form | Solid |
color | off-white to light tan |
InChI | InChI=1S/C19H14N2O4/c22-19(14-5-4-6-16(13-14)21(23)24)20-15-9-11-18(12-10-15)25-17-7-2-1-3-8-17/h1-13H,(H,20,22) |
InChIKey | GDWKBKTVROCPNZ-UHFFFAOYSA-N |
SMILES | C(NC1=CC=C(OC2=CC=CC=C2)C=C1)(=O)C1=CC=CC([N+]([O-])=O)=C1 |
Description and Uses
ICA-105574 is a potent and efficacious hERG channel activator. The primary mechanism by which ICA-105574 potentiates hERG channel activity is by removing hERG channel inactivation. ICA-105574 steeply potentiates current amplitudes more than 10-fold with an EC50 value of 0.5 +/- 0.1 μM and a Hill slope (n(H)) of 3.3 +/- 0.2. ICA-105574 shifts the voltage dependence of Ptype inactivation to a very positive direction and removes the hERG channel from inactivation at physiological membrane potentials[1].
Safety
Symbol(GHS) | GHS07,GHS09 |
Signal word | Warning |
Hazard statements | H317-H319-H400 |
Precautionary statements | P273-P280-P305+P351+P338 |
Hazard Codes | Xi,N |
Risk Statements | 36-43-50/53 |
Safety Statements | 26-36/37-60-61 |
RIDADR | UN 3077 9 / PGIII |